Personal information

Other IDs

Scopus Author ID: 56134112900

Countries

Germany

Activities

Collapse all

Employment (3)

Ruprecht Karls Universität Heidelberg Medizinische Fakultät Mannheim: Mannheim, Baden-Württemberg, DE

2012-01-11 to present (Urology)
Employment
Source: Self-asserted source
Jost von Hardenberg

German Cancer Research Center: Heidelberg, DE

2011-05-01 to 2012-10-31 (Signaling and Functional Genomics)
Employment
Source: Self-asserted source
Jost von Hardenberg

Ruprecht Karls Universität Heidelberg Medizinische Fakultät Mannheim: Mannheim, Baden-Württemberg, DE

2010-05-17 to 2011-05-01 (Urology)
Employment
Source: Self-asserted source
Jost von Hardenberg

Education and qualifications (1)

Universitätsmedizin Rostock: Rostock, Mecklenburg-Vorpommern, DE

2003 to 2009 | M.D.
Education
Source: Self-asserted source
Jost von Hardenberg

Works (48)

The Comprehensive Complication Index (CCI) for improved reporting of complications in endourological stone treatment

Urolithiasis
2021 | Journal article
DOI: 10.1007/s00240-020-01234-2
Source: Self-asserted source
Jost von Hardenberg

The Comprehensive Complication Index for Advanced Monitoring of Complications Following Endoscopic Surgery of the Lower Urinary Tract

Journal of Endourology
2021 | Journal article
DOI: 10.1089/end.2020.0825
Source: Self-asserted source
Jost von Hardenberg

A prospective study on inter-operator variability in semi-robotic software-based MRI/TRUS-fusion targeted prostate biopsies

World Journal of Urology
2021-11-26 | Journal article
DOI: 10.1007/s00345-021-03891-3
Part of ISSN: 0724-4983
Part of ISSN: 1433-8726
Source: Self-asserted source
Jost von Hardenberg

MRT-gestützte minimal-invasive Therapie des Prostatakarzinoms

Der Radiologe
2021-09 | Journal article
DOI: 10.1007/s00117-021-00883-7
Part of ISSN: 0033-832X
Part of ISSN: 1432-2102
Source: Self-asserted source
Jost von Hardenberg

Onset and burden of lower limb lymphedema after radical prostatectomy: a cross-sectional study

Supportive Care in Cancer
2021-09-03 | Journal article
DOI: 10.1007/s00520-021-06520-2
Part of ISSN: 0941-4355
Part of ISSN: 1433-7339
Source: Self-asserted source
Jost von Hardenberg

High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancer

Urologic Oncology: Seminars and Original Investigations
2021-08 | Journal article
DOI: 10.1016/j.urolonc.2021.05.010
Part of ISSN: 1078-1439
Source: Self-asserted source
Jost von Hardenberg

Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy

Urology
2021-06 | Journal article
DOI: 10.1016/j.urology.2021.05.055
Part of ISSN: 0090-4295
Source: Self-asserted source
Jost von Hardenberg

Monoprophylaxis With Cephalosporins for Transrectal Prostate Biopsy After the Fluoroquinolone-Era: A Multi-Institutional Comparison of Severe Infectious Complications

Frontiers in Oncology
2021-06-10 | Journal article
DOI: 10.3389/fonc.2021.684144
Part of ISSN: 2234-943X
Source: Self-asserted source
Jost von Hardenberg

[Intelligent early prostate cancer detection in 2021: more benefit than harm].

Der Urologe. Ausg. A
2021-04-21 | Journal article
DOI: 10.1007/s00120-021-01519-3
PMID: 33881554
Source: Self-asserted source
Jost von Hardenberg

Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer.

World journal of urology
2021-04-21 | Journal article
DOI: 10.1007/s00345-021-03700-x
PMID: 33881557
Source: Self-asserted source
Jost von Hardenberg

RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy

International Journal of Molecular Sciences
2021-04-18 | Journal article
DOI: 10.3390/ijms22084188
Part of ISSN: 1422-0067
Source: Self-asserted source
Jost von Hardenberg

Holmium Versus Thulium Laser Enucleation of the Prostate: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

European urology focus
2021-04-08 | Journal article
DOI: 10.1016/j.euf.2021.03.024
PMID: 33840611
Source: Self-asserted source
Jost von Hardenberg

Factors to improve academic success of scientifically active physicians: A research on research study.

Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen
2021-04-03 | Journal article
DOI: 10.1016/j.zefq.2021.02.001
PMID: 33824094
Source: Self-asserted source
Jost von Hardenberg

Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging–targeted Biopsy: A Large Multicenter Cohort Study

European Urology Focus
2020-10-24 | Journal article
DOI: 10.1016/j.euf.2020.09.015
Source: Self-asserted source
Jost von Hardenberg
grade
Preferred source (of 2)‎

Acceptance, Indications And Chances Of Focal Therapy In Localized Prostate Cancer: A Real-World Perspective Of Urologists In Germany

Journal of Endourology
2020-09-16 | Journal article
DOI: 10.1089/end.2020.0774
Part of ISSN: 0892-7790
Part of ISSN: 1557-900X
Source: Self-asserted source
Jost von Hardenberg

The comprehensive complication index (CCI): proposal of a new reporting standard for complications in major urological surgery

World Journal of Urology
2020-08-19 | Journal article
DOI: 10.1007/s00345-020-03356-z
Part of ISSN: 0724-4983
Part of ISSN: 1433-8726
Source: Self-asserted source
Jost von Hardenberg

Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters

Cancers
2020-07 | Journal article | Author
DOI: 10.3390/cancers12071767
Contributors: Piotr Woźnicki; Niklas Westhoff; Thomas Huber; Philipp Riffel; Matthias F Froelich; Eva Gresser; Jost von Hardenberg; Alexander Mühlberg; Maurice Stephan Michel; Stefan O. Schoenberg et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Phosphodiesterase <i>SMPDL3B</i> Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer

International Journal of Molecular Sciences
2020-06 | Journal article | Author
DOI: 10.3390/ijms21124373
Contributors: Frank Waldbillig; Katja Nitschke; Abdallah Abdelhadi; Jost von Hardenberg; Philipp Nuhn; Malin Nientiedt; Cleo-Aron Weis; Maurice Stephan Michel; Philipp Erben; Thomas Stefan Worst
Source: check_circle
Multidisciplinary Digital Publishing Institute

Treatment decision satisfaction and regret after focal HIFU for localized prostate cancer

World Journal of Urology
2020-06-12 | Journal article
DOI: 10.1007/s00345-020-03301-0
Part of ISSN: 0724-4983
Part of ISSN: 1433-8726
Source: Self-asserted source
Jost von Hardenberg

Prospective Feasibility Study of Single-Shot Antibiotic Prophylaxis in Transrectal Focal Ablation of Prostate Cancer

Urologia Internationalis
2020-05-12 | Journal article
DOI: 10.1159/000507123
Part of ISSN: 0042-1138
Part of ISSN: 1423-0399
Source: Self-asserted source
Jost von Hardenberg

Urologische Forschung in Deutschland

Der Urologe
2020-04-28 | Journal article
DOI: 10.1007/s00120-020-01206-9
Part of ISSN: 0340-2592
Part of ISSN: 1433-0563
Source: Self-asserted source
Jost von Hardenberg

Systematic prostate biopsy still matters: A comprehensive analysis of MRI/TRUS-fusion targeted prostate biopsies across different indications

Urologic Oncology: Seminars and Original Investigations
2019-10 | Journal article
DOI: 10.1016/j.urolonc.2019.07.004
Part of ISSN: 1078-1439
Source: Self-asserted source
Jost von Hardenberg

Prophylactic abdominal or retroperitoneal drain placement in major uro-oncological surgery: a systematic review and meta-analysis of comparative studies on radical prostatectomy, cystectomy and partial nephrectomy

World Journal of Urology
2019-10-29 | Journal article
DOI: 10.1007/s00345-019-02978-2
Part of ISSN: 0724-4983
Part of ISSN: 1433-8726
Source: Self-asserted source
Jost von Hardenberg

Programmed Death Ligand 1 (PD-L1) Status and Tumor-Infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer With Neuroendocrine Differentiation

Clinical Genitourinary Cancer
2019-04 | Journal article
DOI: 10.1016/j.clgc.2018.12.007
Part of ISSN: 1558-7673
Source: Self-asserted source
Jost von Hardenberg

Defining the target prior to prostate fusion biopsy: the effect of MRI reporting on cancer detection

2019-02 | Journal article
DOI: 10.1007/s00345-018-2400-x
Part of ISSN: 0724-4983
Part of ISSN: 1433-8726
Source: Self-asserted source
Jost von Hardenberg

Diagnostik des Therapie-assoziierten, kleinzellig neuroendokrinen Prostatakarzinoms mittels Tumorbiopsie im metastasierten Prostatakarzinom

2019-02 | Journal article
DOI: 10.1007/s00120-019-0858-9
Part of ISSN: 0340-2592
Part of ISSN: 1433-0563
Source: Self-asserted source
Jost von Hardenberg

Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5

2019-01-30 | Journal article
DOI: 10.1007/s00345-019-02651-8
Part of ISSN: 0724-4983
Part of ISSN: 1433-8726
Source: Self-asserted source
Jost von Hardenberg

Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate Cancer

2018 | Journal article
DOI: 10.1159/000490618
Part of ISSN: 2296-5270
Part of ISSN: 2296-5262
Source: Self-asserted source
Jost von Hardenberg

Complete and durable remission of human epidermal growth factor receptor 2-positive metastatic urothelial carcinoma following third-line treatment with trastuzumab and gemcitabine

Urologia Internationalis
2018 | Journal article
DOI: 10.1159/000443280
EID:

2-s2.0-84955619027
Contributors: Wezel, F.; Erben, P.; Gaiser, T.; Budjan, J.; Von Hardenberg, J.; Michel, M.S.; Bolenz, C.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

Prostate cancer detection among readers with different degree of experience using ultra-high b-value diffusion-weighted Imaging: Is a non-contrast protocol sufficient to detect significant cancer?

European Radiology
2018 | Journal article
DOI: 10.1007/s00330-017-5004-8
EID:

2-s2.0-85027154080
Contributors: Hausmann, D.; Aksöz, N.; von Hardenberg, J.; Martini, T.; Westhoff, N.; Buettner, S.; Schoenberg, S.O.; Riffel, P.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

The role of PSMA PET-CT in patients with metastatic prostate cancer,Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom

Radiologe
2018 | Journal article
DOI: 10.1007/s00117-018-0358-8
EID:

2-s2.0-85040667024
Contributors: von Hardenberg, J.; Büsing, K.-A.; Nuhn, P.; Ritter, M.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

Association of training level and outcome of software-based image fusion-guided targeted prostate biopsies

2018-12-17 | Journal article
DOI: 10.1007/s00345-018-2605-z
Part of ISSN: 0724-4983
Part of ISSN: 1433-8726
Source: Self-asserted source
Jost von Hardenberg

HIFU-Hemiablation im lokalisierten Prostatakarzinom

2018-10 | Journal article
DOI: 10.1007/s00120-018-0772-6
Part of ISSN: 0340-2592
Part of ISSN: 1433-0563
Source: Self-asserted source
Jost von Hardenberg

Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation

2018-09 | Journal article
DOI: 10.1016/j.urolonc.2018.05.022
Part of ISSN: 1078-1439
Source: Self-asserted source
Jost von Hardenberg

Database-augmented mass spectrometry analysis of exosomes identifies claudin 3 as a putative prostate cancer biomarker

Molecular and Cellular Proteomics
2017 | Journal article
DOI: 10.1074/mcp.M117.068577
EID:

2-s2.0-85020429751
Contributors: Worst, T.S.; Von Hardenberg, J.; Gross, J.C.; Erben, P.; Schnölzer, M.; Hausser, I.; Bugert, P.; Michel, M.S.; Boutros, M.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

Focal therapy of prostate cancer,Fokale Therapie des Prostatakarzinoms

Urologe
2017 | Journal article
DOI: 10.1007/s00120-017-0488-z
EID:

2-s2.0-85028596164
Contributors: Ganzer, R.; Franiel, T.; Köllermann, J.; Kuru, T.; Baumunk, D.; Blana, A.; Hadaschik, B.; von Hardenberg, J.; Henkel, T.; Köhrmann, K.-U. et al.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

Head-to-head comparison of therapies in localized prostate cancer: Results 10 years after randomization,Kopf-an-Kopf-Vergleich von Therapien im lokalisierten Prostatakarzinom: Ergebnisse 10 Jahre nach Randomisierung

Onkologe
2017 | Journal article
DOI: 10.1007/s00761-017-0184-z
EID:

2-s2.0-85009927007
Contributors: von Hardenberg, J.; Gauter-Fleckenstein, B.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

MRI/TRUS fusion-guided prostate biopsy: Value in the context of focal therapy,MRT/TRUS-fusionierte Biopsiesysteme: Stellenwert bei der fokalen Therapie des Prostatakarzinoms

Urologe
2017 | Journal article
DOI: 10.1007/s00120-016-0268-1
EID:

2-s2.0-84995482325
Contributors: Franz, T.; von Hardenberg, J.; Blana, A.; Cash, H.; Baumunk, D.; Salomon, G.; Hadaschik, B.; Henkel, T.; Herrmann, J.; Kahmann, F. et al.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review

Urologia Internationalis
2017 | Journal article
DOI: 10.1159/000477943
EID:

2-s2.0-85023756211
Contributors: Von Hardenberg, J.; Schwartz, M.; Werner, T.; Fuxius, S.; Strauss, A.; Worst, T.S.; Nuhn, P.; Bolenz, C.; Heinrich, E.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

Precision of MRI/ultrasound-fusion biopsy in prostate cancer diagnosis: an ex vivo comparison of alternative biopsy techniques on prostate phantoms

World Journal of Urology
2017 | Journal article
DOI: 10.1007/s00345-016-1967-3
EID:

2-s2.0-84994453177
Contributors: Westhoff, N.; Siegel, F.P.; Hausmann, D.; Polednik, M.; von Hardenberg, J.; Michel, M.S.; Ritter, M.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

RAB27A, RAB27B and VPS36 are downregulated in advanced prostate cancer and show functional relevance in prostate cancer cells

International Journal of Oncology
2017 | Journal article
DOI: 10.3892/ijo.2017.3872
EID:

2-s2.0-85013074777
Contributors: Worst, T.S.; Meyer, Y.; Gottschalt, M.; Weis, C.-A.; Von Hardenberg, J.; Frank, C.; Steidler, A.; Michel, M.S.; Erben, P.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

The EEF1A2 gene expression as risk predictor in localized prostate cancer

BMC Urology
2017 | Journal article
DOI: 10.1186/s12894-017-0278-3
EID:

2-s2.0-85029596574
Contributors: Worst, T.S.; Waldbillig, F.; Abdelhadi, A.; Weis, C.-A.; Gottschalt, M.; Steidler, A.; Von Hardenberg, J.; Michel, M.S.; Erben, P.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

The role of PSMA PET-CT in patients with metastatic prostate cancer,Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom

Urologe
2017 | Journal article
DOI: 10.1007/s00120-017-0513-2
EID:

2-s2.0-85030535893
Contributors: von Hardenberg, J.; Büsing, K.-A.; Nuhn, P.; Ritter, M.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

Influence of abiraterone acetate on circulating neuromediators in chemotherapy-naïve castration-resistant prostate cancer

Prostate
2016 | Journal article
DOI: 10.1002/pros.23152
EID:

2-s2.0-84986277534
Contributors: von Hardenberg, J.; Schwartz, M.; Werner, T.; Fuxius, S.; Müller, M.; Bolenz, C.; Weiß, C.; Heinrich, E.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

Prognostic significance and functional role of CEP57 in prostate cancer

Translational Oncology
2015 | Journal article
DOI: 10.1016/j.tranon.2015.11.004
EID:

2-s2.0-84949786007
Contributors: Mang, J.; Korzeniewski, N.; Dietrich, D.; Sailer, V.; Tolstov, Y.; Searcy, S.; von Hardenberg, J.; Perner, S.; Kristiansen, G.; Marx, A. et al.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

Prevention of prostate cancer. Long-term results of the Prostate Cancer Prevention Trial (PCPT),Prävention des prostatakarzinoms. Langzeitergebnisse des Prostate Cancer Prevention Trial (PCPT)

Internist
2014 | Journal article
DOI: 10.1007/s00108-014-3544-4
EID:

2-s2.0-84906935135
Contributors: Michel, M.S.; Nitschmann, S.; Von Hardenberg, J.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

Abstracts at congresses of the German Society of Urology: Trends and quality,Beiträge des Kongresses der Deutschen Gesellschaft für Urologie: Trends und Qualität

Urologe - Ausgabe A
2013 | Journal article
DOI: 10.1007/s00120-013-3304-4
EID:

2-s2.0-84884702102
Contributors: Von Hardenberg, J.; Worst, T.; Weiß, C.; Michel, M.S.
Source: Self-asserted source
Jost von Hardenberg via Scopus - Elsevier

Thrombopoietin limits IL-6 release but fails to attenuate liver injury in two hepatic stress models.

Eur J Gastroenterol Hepatol
2009 | Journal article
PMID: 19417678
Source: Self-asserted source
Jost von Hardenberg

Peer review (1 review for 1 publication/grant)

Review activity for Cancers. (1)
How many people are using ORCID?